K151706 is an FDA 510(k) clearance for the Specular Microscope CEM- 530. Classified as Microscope, Specular (product code NQE), Class II - Special Controls.
Submitted by Nidek Co., Ltd. (Gamagori, JP). The FDA issued a Cleared decision on March 17, 2016 after a review of 267 days - an extended review cycle.
This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1850 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.
View all Nidek Co., Ltd. devices
NCT02276638
Completed
Observational
Industry-sponsored
Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality
Comparative Study of the Specular Microscopes for Center Point Method and Corner Point Method for the Measurements of Endothelial Cell Density Measurements, Coefficient of Variation of Endothelial Cell Area and % Hexagonality.
| Condition studied |
Corneal Endothelial Cell Loss |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Gail Torkildsen, MD |
| Sponsor |
Nidek Co. LTD.
(industry)
|
Started 2014-09-01
→
Primary completion 2014-10-01
Primary outcome
Center Method Corneal Endothelial Cell Density
View full study on ClinicalTrials.gov